Clinical Trial Update: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

View source ↗

Summary

An observational safety study evaluated rituximab (MabThera/Rituxan) in granulomatosis with polyangiitis and microscopic polyangiitis. The study has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Status: COMPLETED | Results posted: 2016-08-17